Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome
Top Cited Papers
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 33 (1) , 43-48
- https://doi.org/10.1016/s0168-8278(00)80158-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamineHepatology, 1999
- Hepatorenal SyndromeJournal of the American Society of Nephrology, 1999
- Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansionHepatology, 1998
- Time profile of the haemodynamic effects of terlipressin in portal hypertensionJournal of Hepatology, 1997
- Hepatorenal syndromeDigestive Diseases and Sciences, 1996
- Ischemia- and reperfusion-related injury in pancreatitisDigestive Diseases and Sciences, 1996
- Ischemia-reperfusion-induced pancreatic microvascular injuryDigestive Diseases and Sciences, 1996
- Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†Hepatology, 1996
- Assessment of the renin-angiotensin system in cirrhotic patients: Comparison between plasma renin activity and direct measurement of immunoreactive reninJournal of Hepatology, 1992
- CONVERSION OF TRIGLYCYLVASOPRESSIN TO LYSINE-VASOPRESSIN IN MANJournal of Endocrinology, 1980